<DOC>
	<DOCNO>NCT00697450</DOCNO>
	<brief_summary>This study conduct Europe . Observational study evaluate body weight progress treatment insulin detemir ( Levemir® ) Type 2 patient , previously treat basal insulin</brief_summary>
	<brief_title>Observational Study Weight Effect Insulin Detemir ( Levemir® ) Type 2 Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Type 2 diabetes Current treatment insulin NPH glargine The selection subject discretion individual physician Current treatment insulin detemir Previous enrolment study Hypersensitivity insulin detemir excipients . Women pregnant , breast feeding intention become pregnant within next 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>